P4A to present Cell & Gene Therapy insights at WODC 2018

Partners4Access, a leading market access consultancy specializing in orphan drugs, cell and gene therapy today announced its participation at the World Orphan Drug Congress, an industry conference that brings together rare disease stakeholders under a common platform. The three-day event is being held between November 6-8, 2018 in Barcelona, Spain. P4A’s Sophie Schmitz, Managing Partner…